In individuals without established CVD but with multiple cardiovascular risk factors (such as age 55 years, obesity, hypertension, smoking, dyslipidaemia or albuminuria), a GLP-1 RA with proven benefit could be used to reduce MACE, or an SGLT2i with proven benefit could be used to reduce MACE and HF and improve kidney outcomes
A quick supply sanity-check: a 5 mg vial reconstituted to 2.5 mg/mL holds 20 0.25 mg doses, but because the dose climbs each month, one 5 mg vial does not cover a full titration
If a patient loses 30 pounds in a short window, 6 to 9 pounds of that loss may be lean tissue
Gracias, Zealthy
Most swear by these for temporary relief, particularly when symptoms arent too bad
These intestinal microbes are some of the main producers of the short-chain fatty acids butyrate and propionate